Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Robust clinical trial data demonstrate that GLP-1 receptor agonists produce favorable effects on lipid profiles that may include mechanisms beyond those attributable to weight loss alone
The lowest dose that achieves adequate metabolic control should always be used
Obesity should be viewed as a chronic medical condition requiring a personalized treatment approach there isnt a one-size-fits-all, said Thompson
Companies are introducing once-weekly, auto-injector pens and even oral tablets to increase patient compliance
Also Read: How to Stay Consistent With GLP-1 Medication: Tips, Challenges, Benefits & Long-Term GLP-1 medicines often affect digestion, especially when starting treatment or increasing the dose
However, the data also shows that once older adults are already engaged with GLP-1 treatment, resistance to tablets drops sharply: 43.19% say pills are more appealing than injections 64.94% of injectable users would consider switching This indicates the primary barrier among older adults may not be the pill format itself, but rather initial adoption of GLP-1 treatment in general
